|
WHAT IS
MONOLAURIN
Order
Monolaurin is an anti-microbial agent that protects the immune system
from a range of infectious agents. Monolaurin is a glyceride ester
derivative of lauric acid, a fatty acid found naturally in breast milk
and certain vegetable oils. This fatty acid has been used as a
germicidal agent for centuries. Lauric acid was originally discovered
when microbiologists studied human breast milk to determine the
antiviral substances which protected infants from microbial infections.
It has been shown to protect newborns, whose immune systems are
underdeveloped, from Respiratory Syncytial Virus (RSV) and other
respiratory tract viruses (1,2). Monolaurin was found to have even
greater viral activity than lauric acid. As a dietary supplement,
Monolaurin has shown exciting results as an anti-viral and
anti-bacterial agent.
HOW DOES MONOLAURIN WORK
Monolaurin works by destroying lipid-coated viruses such as herpes,
cytomegalovirus, influenza, and various pathogenic bacteria and protozoa
and it works by binding to the lipid-protein envelope of the virus,
thereby preventing it from attaching and entering host cells, making
infection and replication impossible. Other studies show that Monolaurin
disintegrates the viral envelope, killing the virus.
WHAT IS MONOLAURIN EFFECTIVE IN TREATING
In general, Monolaurin can help treat colds, flu, EBV, shingles, herpes,
and chronic fatigue syndrome. In studies performed at the Respiratory
Virology Branch, Centers for Disease Control, Atlanta, Georgia,
Monolaurin was found effective against 14 human RNA and DNA enveloped
viruses in cell culture (3). These included influenza, RSV, Rubeola,
Newcastle's, Coronavirus, Herpes Simplex types 1 & 2, Epstein-Barr Virus
(EBV) and cytomegalovirus. (Monolaurin has no effect on naked viruses,
such as polio, encephalitis virus, coxsachie, or pox viruses).
Monolaurin removed all measurable infectivity by disintegrating the
virus envelope. In addition to its antiviral effects, monolaurin has
also been shown to have antibacterial activity against Staphylococcus
aureus, Streptococcus agalactiae, Groups A, F & G streptococci,
Chlamydia, H. pylori, and against yeast and fungi as well, including
Candida and ringworm.
HOW CAN I PROTECT MYSELF DURING THE COLD AND FLU SEASON
Monolaurin serves as a valuable nutritional adjunct for people who feel
that they are coming down with a cold or flu. Many physicians have
developed their own clinical protocols in their cold and flu prevention
program and recommend taking several capsules of Monolaurin on an empty
stomach. Monolaurin is not the type of nutritional supplement you have
to take on a daily basis (although many people take it regularly for
prevention purposes), but only when the need arises. If you have a fever
or swollen lymph glands, it is always best to see a physician, but if
you sense the early warning signs of the flu, like sniffles, sore skin
and perhaps a scratchy throat, Monolaurin may offer the first line of
defense.
ANTIBIOTICS, MONOLAURIN AND THE FLU
Antibiotics kill unwanted micro-organisms, but they also kill many
friendly micro-organisms. Monolaurin, on the other hand, does not appear
to have an adverse effect on desirable digestive bacteria, but rather
only on unwanted microorganisms. In addition Monolaurin can reduce the
resistance of germs to antibiotics. Frequent use of antibiotics can lead
to major disruptions in health and especially immune system function.
Antibiotic resistance, resulting from the over-use of prescription
drugs, is one of the biggest problems facing the medical community
today. Resistance is cumulative (and comes in part from antibiotics in
our food supply). That's why it's important to consider starting with
nutritional agents, such as Monolaurin, first. Uncomplicated flu, while
unpleasant, is not life threatening and doesn't necessitate drug
therapy. Nutritional physiologic agents, such as Monolaurin, may be a
good alternative first choice.
IS MONOLAURIN SAFE
Not only is Monolaurin included on the GRAS (Generally Recognized As
Safe) list, but it may, by virtue of its source of origin, be safer than
many other food supplements that are designed to boost the immune
system. One of the safest substances known to man is breast milk. This
is where the monoglyceride of lauric acid (Monolaurin) is found. When an
infant is born, it is totally dependent on food factors in mother's milk
for immune protection. In analyzing the composition of human breast
milk, medical researchers found lauric acid monoglycerides in high
concentrations, which is what led them to study Monolaurin as an
anti-viral agent (4,5). Monolaurin is also found in coconut oil, butter,
and heavy cream; only recently has it been isolated and purified. It is
highly unusual in pharmacology to find chemicals that are toxic to lower
forms of life (bacteria, fungi, and viruses) but non-toxic to man.
DIRECTIONS
For those who feel as if they are coming down with a viral infection,
doctors often recommend taking six capsules on an empty stomach, first
thing in the morning, and for more severe cases, six more at night. (If
you have a sensitive stomach, Monolaurin can be taken with food). The
dose can be tapered off as symptoms decrease. Young children can also
take Monolaurin at a reduced dose. If you are giving Monolaurin to
children (or adults) who have difficulty swallowing capsules, you can
break them open and sprinkle the Monolaurin into something such as
applesauce or yogurt. Some physicians recommend a maintenance dose of
two capsules daily for Epstein-Bar Virus, Herpes 1 & 2, or other chronic
viral conditions. Of course, you should always seek the advice of a
physician if you have fever, pain or if symptoms persist. To treat
herpes virus, some physicians recommend taking 6 capsules of Monolaurin
when there is a flare-up and 2 capsules as a maintenance dose during
dormant periods. Sometimes the herpes virus can be activated by
Monolaurin and then killed, resulting in a Herxheimer-like reaction.
Similar protocols have been used with the Epstein-Barr virus (closely
resembling the herpes virus), which may be responsible for Chronic
Fatigue Syndrome and even MS (16, 17).
Order
REFERENCES
1. Isaacs CE. The antimicrobial function of milk lipids. Adv. Nutr. Res.
10:271-85, 2001.
2. Welsh JK, May JT. Anti-infective properties of breast milk. J.
Pediatrics 94, 1-9, 1979.
3. Hierholzer JC and Kabara JJ. In vitro effects of Monolaurin compounds
on enveloped RNA and DNA viruses. J. Food Safety 4:1, 1982.
4. Kabara JJ. Lipids as host-resistance factors of human milk. Nutr.
Rev. 38:65, 1980.
5. Silver RK et al. Factors in human milk interfering with
influenza-virus activities. Science 123:932-933, 1956.
6. Cohen SS. Strategy for the chemotherapy of infectious diseases.
Science 197:431, 1977.
7. Dulbecco A. Interference with viral multi- plication. In: Virology,
Dulbecco, A. and Ginsberg, H. edit, Harper & Row, Philadelphia, 1980.
8. Kabara JJ et al. Fatty acids and derivatives as antimicrobial agents.
Antimicrob. Agents Chemother. 2:23, 1972.
9. Sands JA et al. Antiviral effects of fatty acids and derivatives. In:
Pharmacological Effects of Lipids. Am. Oil Chem. Soc: Champaign,
1979;75.
10. Beuchat LA. Comparison of antiviral activities of potassium sorbate,
sodium benzoate and glycerol and sucrose esters of fatty acids. Appi.
Environ. Microbiol. 39:1178, 1980.
11. Sands J et al. Extreme sensitivity of enveloped viruses, including
herpes simplex, to long chain unsaturated monoglycerides and alcohols.
Antimicrobial Agents and Chemotherapy 15(1):67-73, 1979.
12. Kohn A. et al. Unsaturated free fatty acids inactivated animal
envelope viruses. Arch. Virol. 66:301-306, 1980.
13. Ismail-Cassim, N et al. Inhibition of the uncoating of bovine
enterovirus by short chain fatty acids. J. Gen. Virol. 71(10):2283-9,
1990.
14. Rabia S. et al. Inactivation of vesicular stomatitis virus by
photosensitization following incubation with a pyrene-fatty acid. Febs.
Let. 270(12):9-10, 1990.
15. Boddie RL and Nickerson SE. Evaluation of postmilking teat
germicides containing Lauricidin, saturated fatty acids, and lactic
acid. J. Dairy Sci. 75(6):1725-30, 1992.
16. Ascherio A., Munger K.L., Lenette E.T., Spiegelman D., Hernan M.A.,
Olek M.J., Hankinson S.E., and Hunter, D.J. Epstein-Barr virus
antibodies and risk of multiple sclerosis: a prospective study. JAMA
286(24:3127-9, Dec. 26th, 2001.
17. Simmons A. Herpes virus and multiple sclerosis. Herpes 8(3):60-3,
Nov. 2001.
ALL INFORMATION IS
EDUCATIONAL AND SHOULD NOT REPLACE THE ADVICE OF YOUR PHYSICIAN. |